Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit

•Patients with rheumatoid arthritis (RA)are at increased risk of atrial fibrillation and ischemic stroke.•There is a knowledge gap on stroke prevention in atrial fibrillation (AF) patients with rheumatoid arthritis (RA).•Thirty-six % of RA patients with AF who had a high estimated stroke risk by CHA2DS2VASc score did not receive oral anticoagulants (OACs).•Our findings suggest that stroke prevention with OAC might not be optimally implemented according to guidelines in these high-risk patients.